The cCAM Biotherapeutics brand, founded in 2009 (Israel), from 402 sister brands and 17477 competing brands. cCAM Biotherapeutics is owned by Merck & Co, listed on the stock exchange of New York The sector of cCAM Biotherapeutics is Drug Manufacturers.

cCAM Biotherapeutics is a brand of Merck & Co (MRK) Share price

Date created : 2009 Business sector Drug Manufacturers

Share price and profitability of the share Merck & Co (cCAM Biotherapeutics)

Buy Merck & Co share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 130.72

Portfolio valuation
Merck & Co (cCAM Biotherapeutics) over 5 years* USD 230.61

Stock market history Merck & Co (cCAM Biotherapeutics)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
Merck & Co

VelosBio
VelosBio
ArQule
ArQule
ConnectMed
ConnectMed
Cubist Pharmaceuticals
Cubist Pharmaceuticals
Antelliq
Antelliq
Merck & Co
Merck & Co
See more brands of Merck & Co

Rival brands
cCAM Biotherapeutics

POINT BIOPHARMA
POINT BIOPHARMA
Icosavax
Icosavax
OGX
OGX
MAUI MOISTURE
MAUI MOISTURE
POLYSPORIN
POLYSPORIN
LACTAID
LACTAID
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands > Pricing Power > 5 major sectors
Desirable brands > Pricing Power > 5 major sectors

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS